Neogenomics Inc reports results for the quarter ended in March - Earnings Summary

NeoGenomics

09/05/2023 24:10

* Neogenomics Inc  NEO.OQ  reported a quarterly adjusted
loss of 9
cents​​ per share for the quarter ended in March. The mean
expectation of thirteen analysts for the quarter was for a loss
of 15 cents per share.
    * Revenue rose 17.1% to $137.22 million from a year ago;
analysts
expected $126.39 million. 
    * Neogenomics Inc's reported EPS for the quarter was a loss
of 25
cents​.
    * The mean earnings estimate of analysts had risen by
about 4.4%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Neogenomics Inc shares had fallen by 12.1% this
quarter and
gained 65.7% so far this year.
    * The company reported a quarterly loss of $30.8 million.
    * Wall Street's median 12-month price target for Neogenomics
Inc
is $20.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
8 at 11:10 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.15          -0.09          Beat
 Dec. 31 2022      -0.16          -0.06          Beat
 Sep. 30 2022      -0.21          -0.14          Beat
 Jun. 30 2022      -0.23          -0.16          Beat